MKI67 and neuroendocrine carcinoma: A total of 1225 (40.27%) patients with IDC had Ki‐67 higher than 15%, and 28 (54.90%) patients with NEC had Ki‐67 higher than 15%, and the difference between the two was statistically significant (p = 0.006).